Education
About Us
Working with TipRanks
Follow Us
Siemens Healthineers (DE:SHL)
:SHL
SHL Stock Chart & Stats
Day’s Range― - ―
52-Week Range€41.21 - €58.48
Previous CloseN/A
Volume31.64K
Average Volume (3M)981.00K
Market Cap
€51.54B
Enterprise Value€53.61B
Total Cash (Recent Filing)€2.85B
Total Debt (Recent Filing)€808.00M
Price to Earnings (P/E)24.8
Beta1.11
Next Earnings
Jul 30, 2025EPS Estimate
0.54Last Dividend Ex-Date
Feb 19, 2025Dividend Yield2.01%
Share Statistics
EPS (TTM)0.56
Shares Outstanding1,128,000,000
10 Day Avg. Volume1,146,761
30 Day Avg. Volume981,002
Financial Highlights & Ratios
PEG Ratio-1.24
Price to Book (P/B)2.97
Price to Sales (P/S)0.00
P/FCF Ratio21.82
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€60.82Price Target Upside31.89% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering14
Siemens Healthineers AG News
PremiumCompany Announcements
Siemens Healthineers Q2 Earnings: Growth Amid Challenges
PremiumCompany Announcements
Siemens Healthineers Q1 2025 Earnings Call Insights
PremiumCompany Announcements
Siemens Healthineers Reports Robust Q1 2025 Performance
PremiumCompany Announcements
Siemens Healthineers Reports Strong Fiscal Year 2024Bulls Say, Bears Say
Bulls Say
Free Cash FlowFree cash flow was EUR197mn, up 64% y/y, significantly higher than the previous year, supporting continued investment in innovation and shareholder returns.
InnovationSiemens Healthineers is at the forefront of innovation and was the first company to obtain FDA approval for the first photon-counting CT for clinical use and continues to be the only company with such technology commercially available.
Revenue GrowthRevenue grew 6.8% y/y to EUR5.9bn, beating full-year guidance of 5% to 6%.
Bears Say
Advanced Therapies SegmentAdvanced therapies segment showed a margin below expectations, attributed to an unfavorable business mix.
Diagnostics Segment PerformanceDiagnostics revenue growth was modest and the adjusted EBIT was materially below expectations.
Tariffs And Trade BarriersThe adjusted EPS forecast range was widened from EUR2.35 to EUR2.50 originally to EUR2.20 to EUR2.50 to factor in anticipated impacts from tariffs and trade barriers which may affect operations in key markets.
Options Prices
Currently, No data available
---
Ownership Overview
― Insiders
3.17%
Mutual Funds
― Other Institutional Investors
93.60% Public Companies and
Individual Investors
SHL FAQ
What was Siemens Healthineers’s price range in the past 12 months?
Siemens Healthineers lowest stock price was €41.21 and its highest was €58.48 in the past 12 months.
What is Siemens Healthineers’s market cap?
Siemens Healthineers’s market cap is €51.54B.
When is Siemens Healthineers’s upcoming earnings report date?
Siemens Healthineers’s upcoming earnings report date is Jul 30, 2025 which is in 54 days.
How were Siemens Healthineers’s earnings last quarter?
Siemens Healthineers released its earnings results on May 07, 2025. The company reported €0.56 earnings per share for the quarter, missing the consensus estimate of €0.566 by -€0.006.
Is Siemens Healthineers overvalued?
According to Wall Street analysts Siemens Healthineers’s price is currently Undervalued.
Does Siemens Healthineers pay dividends?
Siemens Healthineers pays a Annually dividend of €0.949 which represents an annual dividend yield of 2.01%. See more information on Siemens Healthineers dividends here
What is Siemens Healthineers’s EPS estimate?
Siemens Healthineers’s EPS estimate is 0.54.
How many shares outstanding does Siemens Healthineers have?
Siemens Healthineers has 1,128,000,000 shares outstanding.
What happened to Siemens Healthineers’s price movement after its last earnings report?
Siemens Healthineers reported an EPS of €0.56 in its last earnings report, missing expectations of €0.566. Following the earnings report the stock price went down -1.709%.
Which hedge fund is a major shareholder of Siemens Healthineers?
Currently, no hedge funds are holding shares in DE:SHL
Siemens Healthineers AG Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€60.82 (31.89% Upside)
€60.82 (31.89% Upside)
Blogger Sentiment
Bullish
DE:SHL Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth $279.5K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-9.13%
12-Months-Change
Fundamentals
Return on Equity
11.14%
Trailing 12-Months
Asset Growth
1.24%
Trailing 12-Months
Company Description
Siemens Healthineers
Siemens Healthineers AG is a leading global medical technology company headquartered in Erlangen, Germany. It operates in the healthcare sector, providing a broad range of products and services across imaging, diagnostics, advanced therapies, and innovative digital health solutions. The company's core offerings include medical imaging systems, laboratory diagnostics, point-of-care testing, and digital health services that aid in the diagnosis, treatment, and prevention of various diseases and medical conditions.
SHL Company Deck
SHL Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a strong performance with significant growth in revenue, order intake, and segment advancements. However, challenges such as the tariff environment and specific segment pressures, particularly in Varian, were noted. While the company is taking measures to mitigate these challenges, the ongoing uncertainty in the global trade environment presents a cautious outlook.Read More>SHL Stock 12 Month Forecast
Average Price Target
€60.82
▲(31.89%Upside)
Technical Analysis
Fresenius Medical Care AG & Co. KGaA
―
Carl Zeiss Meditec
―
Fresenius SE & Co. KGaA
―
Sartorius
―
Merck KGaA
―